National Planning Corporation’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-7,689
| Closed | -$343K | – | 671 |
|
|
2016
Q1 | $343K | Sell |
7,689
-28,836
| -79% | -$1.29M | 0.03% | 442 |
|
|
2015
Q4 | $1.68M | Sell |
36,525
-8,775
| -19% | -$402K | 0.14% | 171 |
|
|
2015
Q3 | $2.42M | Buy |
45,300
+13,323
| +42% | +$711K | 0.22% | 99 |
|
|
2015
Q2 | $1.87M | Buy |
31,977
+19,695
| +160% | +$1.15M | 0.17% | 130 |
|
|
2015
Q1 | $695K | Sell |
12,282
-1,854
| -13% | -$105K | 0.06% | 270 |
|
|
2014
Q4 | $722K | Buy |
14,136
+300
| +2% | +$15.3K | 0.05% | 310 |
|
|
2014
Q3 | $655K | Sell |
13,836
-150
| -1% | -$7.1K | 0.05% | 337 |
|
|
2014
Q2 | $630K | Buy |
13,986
+432
| +3% | +$19.5K | 0.05% | 342 |
|
|
2014
Q1 | $576K | Hold |
13,554
| – | – | 0.05% | 335 |
|
|
2013
Q4 | $533K | Buy |
13,554
+2,178
| +19% | +$85.6K | 0.05% | 347 |
|
|
2013
Q3 | $407K | Buy |
11,376
+1,401
| +14% | +$50.1K | 0.04% | 400 |
|
|
2013
Q2 | $329K | Buy |
+9,975
| New | +$329K | 0.04% | 369 |
|